| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.9 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.0093 | 0.9 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.0083 | 0.9 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.0048 | 0.9 |